Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Delivery of Drugs: Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems
    Unavailable
    Delivery of Drugs: Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems
    Unavailable
    Delivery of Drugs: Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems
    Ebook615 pages5 hours

    Delivery of Drugs: Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Delivery of Drugs: Expectations and Realities of Multifunctional Drug Delivery Systems, Volume Two examines the formulation of micro-nanosized drug delivery systems and recaps opportunities for using physical methods to improve efficacy via mechano-, electroporation. The book highlights innovative delivery methods like PIPAC, including discussions on the regulatory aspects of complex injectables. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects.This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stakeholders. This level of discussion makes it a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems.
    • Delivery of Drugs examines the fabrication, optimization, scale-up, biological aspects, regulatory and clinical success of various micro and nano drug delivery systems. The volume covers site and organ specific targeting approaches, technologies used in preparation of micro - nanoparticles, challenges of complex type of drug delivery forms and role of physical methods in achieving targeted drug effect. Written by a diverse range of international researchers the chapters examine the specific aspects of characterization and manufacturing of drug delivery system for pharmaceutical application and its regulatory aspects
    • The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers
    • Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems
    LanguageEnglish
    PublisherElsevier Science
    Release dateFeb 1, 2020
    ISBN9780128177778
    Unavailable
    Delivery of Drugs: Volume 2: Expectations and Realities of Multifunctional Drug Delivery Systems

    Related to Delivery of Drugs

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Q & A

      Nov 27, 2021

      With the COVID19 pandemic exerting enormous pressure on the healthcare infrastructure, the sector finds itself under the compulsion to step up. In this interview Dr. G.V. Sampath, Chairman, Naruvi Hospitals, Vellore addresses how India can make optim

      2 min read

    • Article

      Pulse Of The Matter

      Jul 31, 2021

      Pulse Of The Matter
      2 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Cancer The New Cures

      Sep 24, 2022

      Cancer The New Cures
      17 min read

    • Article

      The Modi Government’s Nerve Centre For Covid-19 Management

      May 8, 2021

      Chairperson: Dr Vinod Paul, NITI Aayog Members: Dr Renu Swaroop, Secretary, Biotechnology; V. Thiruppugazh of the NDMA; officials from the MoHFW, cabinet secretariat and a director-level officer from the PMO; Dr Randeep Guleria, director of AIIMS; D

      3 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      This Method Cuts Toxic Side Effects of Nanodrug Chemo

      Dec 5, 2017

      Administering an FDA-approved nutrition source called Intralipid before nanodrug chemotherapy can reduce the amount of the toxic drugs that settle in the spleen, liver, and kidneys, researchers report. “This methodology could have a major impact in t

      1 min read

    • Article

      Detection Gaps

      Apr 18, 2020

      Detection Gaps
      7 min read

    • Article

      Failing The Test

      May 2, 2020

      Failing The Test
      8 min read

    • Article

      American Chemistry Council Uses Disinformation to Target PFAS Safeguards

      Aug 8, 2022

      Last week,  the American Chemistry Council (ACC), the chemical industry’s trade association, submitted a highly deceptive petition challenging the EPA’s June decision to set significantly stricter health advisories for four PFAS chemicals. In its sta

      5 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    Related categories

    Reviews for Delivery of Drugs

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words